Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Admon

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Scientific Reports|November 13, 2019
Therapeutic potential of N-acetylcysteine in acrylamide acute neurotoxicity in adult zebrafishMelissa Faria, Eva Prats, Cristian Gómez-Canela, et al.
Scientific Reports|February 7, 2020
Publisher Correction: Therapeutic potential of N-acetylcysteine in acrylamide acute neurotoxicity in adult zebrafishMelissa Faria, Eva Prats, Cristian Gómez-Canela, et al.
Scientific Reports|January 17, 2020
Targeting redox metabolism: the perfect storm induced by acrylamide poisoning in the brainDemetrio Raldúa, Marta Casado, Eva Prats, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigensSofia Khazan-Kost, Gal Cafri, Dganit Melamed Kadosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2016
Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitinationOri Braten, Ido Livneh, Tamar Ziv, et al.
Cell|April 11, 2015
KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growthYelena Kravtsova-Ivantsiv, Inna Shomer, Victoria Cohen-Kaplan, et al.
Nature Communications|February 16, 2020
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Joo Sang Lee, Eilon Barnea, et al.
Iscience|February 8, 2021
Healthy cells functionally present TAP-independent SSR1 peptides: implications for selection of clinically relevant antigensAntonius A de Waard, Tamara Verkerk, Kelly Hoefakker, et al.
Nature Biotechnology|October 6, 2022
Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumorsAssaf Kacen, Aaron Javitt, Matthias P Kramer, et al.
Proteomics|May 24, 2018
Minimal Information About an Immuno-Peptidomics Experiment (MIAIPE)Jennie R Lill, Peter A van Veelen, Stefan Tenzer, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Scientific Reports|November 13, 2019
Therapeutic potential of N-acetylcysteine in acrylamide acute neurotoxicity in adult zebrafishMelissa Faria, Eva Prats, Cristian Gómez-Canela, et al.
Scientific Reports|February 7, 2020
Publisher Correction: Therapeutic potential of N-acetylcysteine in acrylamide acute neurotoxicity in adult zebrafishMelissa Faria, Eva Prats, Cristian Gómez-Canela, et al.
Scientific Reports|January 17, 2020
Targeting redox metabolism: the perfect storm induced by acrylamide poisoning in the brainDemetrio Raldúa, Marta Casado, Eva Prats, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigensSofia Khazan-Kost, Gal Cafri, Dganit Melamed Kadosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2016
Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitinationOri Braten, Ido Livneh, Tamar Ziv, et al.
Cell|April 11, 2015
KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growthYelena Kravtsova-Ivantsiv, Inna Shomer, Victoria Cohen-Kaplan, et al.
Nature Communications|February 16, 2020
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Joo Sang Lee, Eilon Barnea, et al.
Iscience|February 8, 2021
Healthy cells functionally present TAP-independent SSR1 peptides: implications for selection of clinically relevant antigensAntonius A de Waard, Tamara Verkerk, Kelly Hoefakker, et al.
Nature Biotechnology|October 6, 2022
Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumorsAssaf Kacen, Aaron Javitt, Matthias P Kramer, et al.
Proteomics|May 24, 2018
Minimal Information About an Immuno-Peptidomics Experiment (MIAIPE)Jennie R Lill, Peter A van Veelen, Stefan Tenzer, et al.
Pageof 12